BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 35659599)

  • 1. Expression relationship and significance of NEAT1 and miR-27a-3p in serum and cerebrospinal fluid of patients with Alzheimer's disease.
    He L; Chen Z; Wang J; Feng H
    BMC Neurol; 2022 Jun; 22(1):203. PubMed ID: 35659599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-non-coding RNA NEAT1 is a novel target for Alzheimer's disease progression via miR-124/BACE1 axis.
    Zhao MY; Wang GQ; Wang NN; Yu QY; Liu RL; Shi WQ
    Neurol Res; 2019 Jun; 41(6):489-497. PubMed ID: 31014193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA NEAT1 promotes Alzheimer's disease by down regulating micro-27a-3p.
    Dong LX; Zhang YY; Bao HL; Liu Y; Zhang GW; An FM
    Am J Transl Res; 2021; 13(8):8885-8896. PubMed ID: 34540002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.
    Wang X; Li M; Hu Y
    Physiol Res; 2023 Dec; 72(6):833-841. PubMed ID: 38215068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-29c-3p May Promote the Progression of Alzheimer's Disease through BACE1.
    Cao Y; Tan X; Lu Q; Huang K; Tang X; He Z
    J Healthc Eng; 2021; 2021():2031407. PubMed ID: 34956559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer's disease.
    Zhang J; Hu M; Teng Z; Tang YP; Chen C
    J Neurosci; 2014 Nov; 34(45):14919-33. PubMed ID: 25378159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-340 Reduces the Accumulation of Amyloid-β Through Targeting BACE1 (β-site Amyloid Precursor Protein Cleaving Enzyme 1) in Alzheimer's Disease.
    Tan X; Luo Y; Pi D; Xia L; Li Z; Tu Q
    Curr Neurovasc Res; 2020; 17(1):86-92. PubMed ID: 31957613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA BACE1-AS Promotes Autophagy-Mediated Neuronal Damage Through The miR-214-3p/ATG5 Signalling Axis In Alzheimer's Disease.
    Zhou Y; Ge Y; Liu Q; Li YX; Chao X; Guan JJ; Diwu YC; Zhang Q
    Neuroscience; 2021 Feb; 455():52-64. PubMed ID: 33197504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties.
    Chopra N; Wang R; Maloney B; Nho K; Beck JS; Pourshafie N; Niculescu A; Saykin AJ; Rinaldi C; Counts SE; Lahiri DK
    Mol Psychiatry; 2021 Oct; 26(10):5636-5657. PubMed ID: 31942037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA NEAT1 promotes hypoxia-induced renal tubular epithelial apoptosis through downregulating miR-27a-3p.
    Jiang X; Li D; Shen W; Shen X; Liu Y
    J Cell Biochem; 2019 Sep; 120(9):16273-16282. PubMed ID: 31090110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-22-3p Regulates Amyloid β Deposit in Mice Model of Alzheimer's Disease by Targeting Mitogen-activated Protein Kinase 14.
    Ji Q; Wang X; Cai J; Du X; Sun H; Zhang N
    Curr Neurovasc Res; 2019; 16(5):473-480. PubMed ID: 31713484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-β induced neurotoxicity and neuroinflammation by sponging miR-374b-5p.
    Zhang J; Wang R
    Exp Gerontol; 2021 Feb; 144():111180. PubMed ID: 33279663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease.
    Ke S; Yang Z; Yang F; Wang X; Tan J; Liao B
    Yonsei Med J; 2019 Jul; 60(7):640-650. PubMed ID: 31250578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects.
    Long JM; Ray B; Lahiri DK
    J Biol Chem; 2014 Feb; 289(8):5184-98. PubMed ID: 24352696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Combined Therapy of Berberine Treatment with lncRNA BACE1-AS Depletion Attenuates Aβ
    Ge Y; Song X; Liu J; Liu C; Xu C
    Neurochem Res; 2020 Apr; 45(4):741-751. PubMed ID: 31898085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNA BACE1-AS Modulates Isoflurane-Induced Neurotoxicity to Alzheimer's Disease Through Sponging miR-214-3p.
    He W; Chi S; Jin X; Lu J; Zheng W; Yan J; Zhang D
    Neurochem Res; 2020 Oct; 45(10):2324-2335. PubMed ID: 32681443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of long noncoding RNA XIST attenuated Alzheimer's disease-related BACE1 alteration through miR-124.
    Yue D; Guanqun G; Jingxin L; Sen S; Shuang L; Yan S; Minxue Z; Ping Y; Chong L; Zhuobo Z; Yafen W
    Cell Biol Int; 2020 Feb; 44(2):630-636. PubMed ID: 31743528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
    Liu CG; Wang JL; Li L; Wang PC
    Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-361-3p inhibits β-amyloid accumulation and attenuates cognitive deficits through targeting BACE1 in Alzheimer's disease.
    Ji Y; Wang D; Zhang B; Lu H
    J Integr Neurosci; 2019 Sep; 18(3):285-291. PubMed ID: 31601077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the Expression of Amyloid Precursor Protein Cleaving Enzymes mRNA in Alzheimer Peripheral Blood.
    Wongchitrat P; Pakpian N; Kitidee K; Phopin K; Dharmasaroja PA; Govitrapong P
    Curr Alzheimer Res; 2019; 16(1):29-38. PubMed ID: 30411686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.